Cetuximab (EGFR inhibitor) clinical trials

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

This study is testing a new drug, CRB-701, for throat and tonsil cancer (oropharyngeal squamous cell carcinoma). It's for people who have already had treatment for their cancer. Researchers want to see if CRB-701 works better than standard treatments and if it is safe.